143 related articles for article (PubMed ID: 38583808)
41. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
[TBL] [Abstract][Full Text] [Related]
42. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
Havranek KE; Jimenez AR; Acciani MD; Lay Mendoza MF; Reyes Ballista JM; Diaz DA; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33353101
[TBL] [Abstract][Full Text] [Related]
43. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.
Messaoudi I; Barron A; Wellish M; Engelmann F; Legasse A; Planer S; Gilden D; Nikolich-Zugich J; Mahalingam R
PLoS Pathog; 2009 Nov; 5(11):e1000657. PubMed ID: 19911054
[TBL] [Abstract][Full Text] [Related]
44. GeXPS multiplex PCR analysis of the simian varicella virus transcriptome in productively infected cells in culture and acutely infected ganglia.
Nagel MA; Choe A; Gilden D; Traina-Dorge V; Cohrs RJ; Mahalingam R
J Virol Methods; 2013 Oct; 193(1):151-8. PubMed ID: 23769859
[TBL] [Abstract][Full Text] [Related]
45. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
Chiem K; Ye C; Martinez-Sobrido L
Curr Protoc Microbiol; 2020 Dec; 59(1):e126. PubMed ID: 33048448
[TBL] [Abstract][Full Text] [Related]
46. Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of bcl-2 expression.
Pugazhenthi S; Gilden DH; Nair S; McAdoo A; Wellish M; Brazeau E; Mahalingam R
J Virol; 2009 Sep; 83(18):9273-82. PubMed ID: 19605493
[TBL] [Abstract][Full Text] [Related]
47. Simian varicella in old world monkeys.
Gray WL
Comp Med; 2008 Feb; 58(1):22-30. PubMed ID: 19793453
[TBL] [Abstract][Full Text] [Related]
48. Identification of simian varicella virus gene 21 promoter region using green fluorescent protein.
Mahalingam R; Wellish M; White T; Gilden DH
J Virol Methods; 2000 Apr; 86(1):95-9. PubMed ID: 10713380
[TBL] [Abstract][Full Text] [Related]
49. The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication.
Tylor S; Andonov A; Cutts T; Cao J; Grudesky E; Van Domselaar G; Li X; He R
Can J Microbiol; 2009 Mar; 55(3):254-60. PubMed ID: 19370068
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
[TBL] [Abstract][Full Text] [Related]
51. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS
Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312
[TBL] [Abstract][Full Text] [Related]
52. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
[TBL] [Abstract][Full Text] [Related]
53. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
54. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Coronavirus Entry
Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
[TBL] [Abstract][Full Text] [Related]
56. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.
Herrmann A; Jungnickl D; Cordsmeier A; Peter AS; Überla K; Ensser A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638527
[TBL] [Abstract][Full Text] [Related]
57. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
[TBL] [Abstract][Full Text] [Related]
58. Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.
Yamate M; Yamashita M; Goto T; Tsuji S; Li YG; Warachit J; Yunoki M; Ikuta K
Microbes Infect; 2005 Dec; 7(15):1530-40. PubMed ID: 16269264
[TBL] [Abstract][Full Text] [Related]
59. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
[TBL] [Abstract][Full Text] [Related]
60. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
